- Moderna Therapeutics is a biotechnology company that researches and develops protein therapies based on novel messenger RNA technology
Moderna Therapeutics Net worth 2024 (estimated)
| How much is Moderna Therapeutics worth? | Under review
|
Moderna Therapeutics facts
- The company’s technology uses mRNA made of nucleotide analogs to trigger the body’s natural processes to produce proteins inside the human cell
- This approach has the potential to produce therapeutic proteins in vivo to treat a wide range of diseases, including those that cannot be effectively treated with existing methods to develop and manufacture drugs
- Moderna’s pipeline of mRNA product candidates covers a broad expanse of drug modalities, including vaccines (both for infectious diseases and personalized cancer vaccines), intracellular/transmembrane proteins, intratumoral expression, and secreted antibodies and proteins
- Each modality represents a distinct approach to using the mRNA platform to encode proteins that achieve a therapeutic benefit, enabling the company to develop numerous drug candidates across a wide array of therapeutic areas
- The company was founded in 2011 in Cambridge, Massachusetts through funding from Flagship Ventures
- Moderna’s founders include Noubar Afeyan of Flagship Ventures, Kenneth R
- Chien of Harvard University and the Karolinska Institutet, Robert S
- Langer of the Massachusetts Institute of Technology and Derrick Rossi of Boston Children’s Hospital
- Moderna is led by Stéphane Bancel, CEO and Director of the Board; Stephen Hoge, M
- D
Bio / wiki sources: Wikipedia, accounts on social media, content from our users.
Wiki & wealth sources: Wikipedia, TMDb, social media accounts, users content, wealth specialized websites
We do our best for being accurate. If something seems incorrect, please contact us! |
|